Novavax (NVAX.O) has told the European Union it plans to begin delivering its COVID-19 vaccine to the bloc towards the end of this year, new guidance that could lead to
WORLD FACES COVID-19 “VACCINE APARTHEID”
Even countries that hosted vaccine trials — like Argentina, South Africa, Brazil, and Turkey — will not receive adequate supplies.